Ryan T.
14 months. 4 PT rounds. 3 cortisone shots. A surgical consult. Then a clinically supervised peptide protocol changed everything.
A chronic SLAP labral tear that wasn't responding to anything — resolved without surgery in 6 months using the Wolverine Stack: BPC-157 and TB-500, pharmacy-grade, clinically dosed, biomarker-tracked.
The Man Who Couldn't Afford to Stop
Ryan is a 38-year-old commercial high-rise construction supervisor — married, father of a 6 and 9-year-old, sole income earner, and a weekend competitive CrossFit athlete. His identity is built on physical capability. His livelihood depends on it. When a SLAP labral tear ended his overhead capacity 14 months before he came to FLOA, the standard medical pathway offered him exactly one option: 6 months off work for arthroscopic labral repair, with possible permanent range-of-motion loss. That wasn't a solution. That was a catastrophe.
In those 14 months, Ryan had done everything the conventional system offered. Four rounds of physical therapy — the last a 12-week sports medicine protocol. Three cortisone injections at 4-month intervals, each with diminishing returns. Daily ibuprofen 600mg for over 6 months. He had even self-sourced a 4-week BPC-157 cycle from a research peptide website — felt some improvement, but had no way to know if the dosing was accurate or the product legitimate. Nothing had returned him to full function.
He came to FLOA with one clear objective: resolve the injury without surgery, with a clinically supervised protocol he could actually trust, while keeping his job, his training, and his life intact.
What He Came In With
- Chronic SLAP labral tear — MRI-confirmed, 14 months unresolved despite full conventional treatment
- Complete loss of overhead pressing and pulling — no pull-ups, snatches, jerks, or kipping movements
- Back squat 60 lbs below competition max from compensatory movement patterns and systemic inflammation
- Sleep interrupted 3–4 nights per week by shoulder pain (Whoop average 6.2 hrs, recovery score 64)
- Systemic inflammation: hs-CRP 3.2 mg/L, ESR 18 — both elevated
- Chronic NSAID use: 600mg ibuprofen daily for 6+ months — gut barrier and cardiovascular risk accumulating
- Three cortisone injections with diminishing returns — further tissue degradation concern
- Prior self-sourced peptide cycle: unverified product quality, undocumented dosing, no biomarker tracking
- Surgical consult pending: arthroscopic labral repair recommended, 6 months downtime, ROM loss possible
- Financial and identity pressure: sole earner, physically demanding job, athletic identity at stake
The Wolverine Stack — Clinically Designed
MRI and surgical consult notes reviewed. Full inflammatory and hormone panel. IGF-1 and growth hormone axis baseline. DEXA body composition assessment. Sleep assessment via Whoop data review. NSAID impact evaluation covering gut barrier integrity and cardiovascular risk. Protocol design and stacking strategy finalized by FLOA's prescribing medical team before a single peptide was administered.
Body Protection Compound 157 administered subcutaneously twice daily at 250 mcg, with injection sites rotated proximal to the affected shoulder for localized tissue concentration. BPC-157 drives angiogenesis (new blood vessel formation into damaged tissue), upregulates growth factor expression, and accelerates tendon and ligament healing at the cellular level. Maintained at consistent dose throughout the 8-week intensive phase.
Thymosin Beta-500 dosed at 5mg twice weekly during the 4-week loading phase, then 5mg weekly for maintenance. TB-500 enhances actin polymerization and cellular migration — mobilizing repair cells to injury sites throughout the body. The systemic delivery complements BPC-157's more localized action, addressing the full extent of soft tissue damage including secondary rotator cuff inflammation.
BPC-157 and TB-500 were chosen specifically for their complementary mechanisms: BPC-157 operates at the growth factor and angiogenesis level, rebuilding the tissue environment; TB-500 operates at the cytoskeletal level, directing repair cells into position. Together they address labral, tendon, and connective tissue repair through multiple simultaneous pathways — a meaningful clinical advantage over either peptide used alone.
All peptides sourced exclusively from a licensed compounding pharmacy with certificates of analysis available. This directly addressed Ryan's prior self-sourcing risk — unknown purity, undocumented concentration, and unverifiable peptide identity. Clinical-grade sourcing is not a preference; it is a prerequisite for predictable outcomes and patient safety.
Protected training progression: full lower body maintained, isolation work for unaffected upper body, light therapeutic shoulder loading per PT collaboration — no overhead loading until week 6 reassessment. Structured ibuprofen taper initiated at week 1. Protein target 200g/day; collagen 20g daily with vitamin C for connective tissue substrate. Magnesium glycinate increased to 500mg for sleep support. Cycling protocol: 8 weeks intensive, 4 weeks off, maintenance reassessment.
Phase by Phase
Sleep Returns — Inflammation Begins to Drop
Sleep continuity improving within 5 days — nighttime pain wakeups reduced from 4 per week to 1. Subjective inflammation reduction noticeable. Mild post-injection soreness manageable and resolving. The most immediate signal: waking up without shoulder pain for the first time in over a year.
→ Pain wakeups 4x/week → 1x; sleep continuity restoring
40% Pain Reduction — Off Ibuprofen by Week 3
Pain on overhead movement reduced approximately 40%. Range of motion improving measurably. hs-CRP dropped from 3.2 to 2.1 — systemic inflammation already responding. Ibuprofen tapered off by week 3 with only mild transient flare-ups — ending a 6-month daily NSAID dependency that had been quietly accumulating risk.
→ 40% pain reduction; hs-CRP 2.1; off ibuprofen week 3
Overhead Pressing Reintroduced — Pull-Ups Returning
Light overhead pressing reintroduced with empty barbell — the first overhead loading in over a year. Pull-up tolerance returning. Continuous sleep fully restored — pain wakeups eliminated. Lower body training capacity confirmed at 100%. The shoulder was no longer the ceiling on everything else.
→ Overhead loading reintroduced; sleep fully restored; LB training 100%
MRI Confirms Partial Labral Healing
Repeat MRI at month 3 shows partial labral healing with reduced surrounding inflammation — structural evidence of tissue repair, not just symptom management. Pain-free overhead pressing at moderate loads. Pull-ups restored to 8–10 unbroken. hs-CRP 0.9 — inflammation essentially resolved. Protocol entered maintenance phase.
→ MRI confirms healing; pull-ups restored; hs-CRP 0.9; maintenance phase begins
Cycling Protocol — Competition Lifts Restored at 90%
4-week off cycle followed by maintenance dosing (BPC-157 250 mcg daily, TB-500 5mg weekly x 4 weeks). All competition movement patterns — snatch, jerk, pull-ups — restored pain-free. Back squat returned to pre-injury max. Whoop recovery score averaging 86. Ryan returned to competitive CrossFit. Surgery never happened.
→ All lifts restored at 90%+ of pre-injury max; back to competition; no surgery
"Four PT rounds and three cortisone injections hadn't restored him — because cortisone suppresses inflammation without repairing tissue, and PT cannot rebuild a mechanically compromised labrum. BPC-157 and TB-500 don't mask the injury. They change the tissue environment at the cellular level. The month 3 MRI wasn't a surprise. It was the expected result of a protocol designed to produce structural healing, not symptom management."
What Changed at 6 Months
Structural Healing
MRI at month 3 confirmed partial labral healing with reduced surrounding inflammation — objective structural evidence, not just symptom relief. Full function restored by month 6.
Performance Restored
Pull-ups, snatch, jerk, and kipping movements all restored pain-free. Back squat returned to pre-injury competition max. Overhead capacity fully functional at 90%+ of prior peak.
Inflammation Resolved
hs-CRP from 3.2 → 0.9 mg/L. ESR from 18 → 8. Systemic inflammatory burden eliminated — and with it, the chronic NSAID use that had been accumulating its own downstream risks.
Sleep Fully Restored
Pain wakeups eliminated by month 2. Whoop sleep score from 64 → 86. Recovery score from 64 → 86 average — a ~50% improvement in inter-session recovery time that cascaded into every aspect of training and work performance.
Off Chronic NSAIDs
Daily 600mg ibuprofen — taken for 6+ months — tapered and eliminated by week 3. Gut barrier and cardiovascular risk exposure ended. No pain management substitutes required.
Surgery Avoided
Arthroscopic labral repair — 6 months off work, possible permanent ROM loss, financially unviable — never performed. Career, income, and identity protected without going under the knife.
| Category | What Changed |
|---|---|
| Surgery | Recommended arthroscopic repair — avoided entirely; structural healing confirmed on MRI |
| NSAIDs | Daily 600mg ibuprofen for 6+ months → completely off by week 3 of protocol |
| Sleep | 3–4 pain wakeups per week → zero; Whoop sleep score 64 → 86 |
| Overhead Lifting | Zero overhead capacity → pain-free pressing and pulling restored by month 2 |
| Pull-Ups | Impossible for 14 months → 8–10 unbroken by month 3 |
| Snatch / Jerk | Fully pain-free by month 6 — competition movements restored |
| Back Squat | 60 lbs below competition max → returned to pre-injury max by month 6 |
| Recovery Time | ~50% reduction in inter-session recovery time (Whoop recovery score 64 → 86) |
| Clinical Oversight | Moved from self-sourced, unverified research peptides to pharmacy-grade, COA-verified, biomarker-tracked protocol |
| Identity & Career | Physical capability, job security, and athletic competition all preserved — the outcomes that mattered most |
"I'd done everything they told me to do — PT, cortisone, rest. Nothing worked. I was staring down six months off work and the chance I'd never move the same way again. I'd even tried sourcing BPC-157 myself but had no idea what I was actually injecting. FLOA put together a real protocol, real sourcing, tracked my labs the whole way through, and my month 3 MRI showed actual healing. I'm back competing. I never had the surgery. That's the only outcome that mattered to me."
Clinical Takeaways
Ryan's case illustrates a critical distinction between symptom suppression and tissue repair. Cortisone injections reduce inflammation — but they do not rebuild damaged connective tissue. Physical therapy restores movement patterns and muscular support — but it cannot mechanically repair a torn labrum. Ryan had exhausted both tools completely. What he needed was a protocol that operated at the cellular level, creating the biological conditions for the tissue itself to heal.
BPC-157 and TB-500 work through complementary and synergistic mechanisms that neither peptide achieves alone. BPC-157 promotes angiogenesis — new blood vessel growth into oxygen-deprived scar tissue — and upregulates growth factor expression at the injury site. TB-500 drives actin polymerization and cellular migration, mobilizing repair cells throughout the body toward sites of damage. Together, they rebuild the tissue environment rather than muting the signal that something is wrong. The month 3 MRI showing partial labral healing was structural confirmation of that process — not a placebo effect.
The self-sourcing risk Ryan had taken previously also deserves attention. Research peptide websites operate outside pharmaceutical oversight — purity, concentration, and peptide identity are unverified. A protocol that uses the right peptides at unverified quality produces unpredictable results. Pharmacy-grade sourcing with certificates of analysis is not a preference. It is the clinical standard that makes outcomes like Ryan's reproducible rather than lucky.
Before You Schedule That Surgery — Read This
If you've been told surgery is your only option for a soft tissue injury — after cortisone, PT, and months of waiting — there may be a protocol worth exploring first. Clinically supervised, pharmacy-grade, biomarker-tracked. Not self-sourced. Not guesswork.
Individual results vary. This case study is for educational purposes only. © Dr. Jones DC — FLOA Protocol.